查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827832

2025年全球自行注射市場報告

Self-Injections Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，自行注射市場規模強勁成長，從2024年的96.9億美元增加至2025年的102.2億美元，複合年成長率為5.5%。這段期間的成長可歸因於慢性病發病率的上升、患者自主權的增強、監管機構的支持、對家庭醫療保健的偏好以及成本效益。

預計未來幾年自行注射市場規模將強勁成長，到2029年將達到139.3億美元，複合年成長率為8.1%。預測期內的成長可歸因於疫情和遠端醫療的影響、新興市場的擴張、以患者為中心的醫療保健、藥物輸送優勢以及個人化醫療趨勢。預測期內的主要趨勢包括智慧技術的整合、生技藥品應用的增加、微型化和穿戴式裝置、安全性能的增強以及自動注射器的普及。

自行注射是指個人在沒有醫療保健專業人員協助的情況下透過設備自行注射藥物的行為，允許患者獨立管理他們的藥物治療。

自行注射的主要類型包括裝置和劑型。這些裝置可讓患者自行注射需要注射的藥物，而無需依賴醫療專業人員。自動注射器可用於多種給藥途徑，包括皮膚、循環系統、肌肉骨骼系統、器官和中樞神經系統。劑量類型包括單劑量和多劑量，並適用於自體免疫疾病、荷爾蒙失調、腫瘤學、罕見疾病、疼痛管理和呼吸治療等應用。這些裝置透過各種管道銷售，包括醫院、藥房、診所、藥局和線上藥局。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快研發更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供自行注射市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的自行注射自行注射市場細分、市場趨勢和機遇，以及在自行注射行業取得成功所需的其他數據。本自行注射市場研究報告對該行業的自行注射和未來趨勢進行了詳細分析，提供了所有必要的完整觀點。

未來五年預測成長率為8.1%，較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國，導致自動注射器彈簧和劑量計數裝置（主要由瑞典和丹麥供應）以及慢性病管理設備的成本上升。此外，由於相互關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛。

預計未來糖尿病患者數量的成長將推動自行注射市場的成長。糖尿病是一種疾病，胰臟（負責產生胰島素的器官）分泌的胰島素不足，會導致血糖值下降，並引發心臟病、視力喪失和腎臟疾病等嚴重健康問題。自行注射使糖尿病患者能夠自行注射胰島素和其他藥物，有助於調節血糖值，並防止糖分攝取過量，無需醫療專業人員的協助。例如，根據總部位於比利時的全球糖尿病盛行率、治療和護理綜合數據資訊來源IDF糖尿病地圖集的數據，預計全球糖尿病患者數量將從2030年的6.43億增加1.4億，到2045年將達到7.83億。目前，全球有5.37億成年人患有糖尿病，其中超過75%居住在中低收入國家。因此，糖尿病患者數量的增加將顯著促進自行注射市場的擴張。

遠端保健和遠端醫療的興起預計將在未來推動自行注射市場的成長。遠端醫療利用通訊技術遠端提供廣泛的醫療服務和訊息，而遠端醫療則專注於遠距臨床諮詢和醫療服務。這些數位健康平台支援虛擬諮詢，並允許醫療保健提供者遠端準備自行注射藥物。患者還可以從有關如何正確進行自行注射的虛擬訓練課程中受益。此外，遠端醫療有助於即時監控患者的用藥依從性、持續的疾病管理以及輕鬆存取遠端藥房服務進行藥物分配。遠端醫療的便利性，尤其是在大流行期間，提高了患者的參與度並改善了獲得專科護理的整體機會，極大地促進了自行注射市場的成長。例如，根據美國政府資訊提供者Telehealth.HHS.gov的數據，2023年第四季遠端保健使用者數量達到約21,883,731人，較上一季增加2,783,159人（13%）。因此，遠端保健和遠端醫療的興起正在推動自行注射市場的擴張。

胰島素注射解決方案的創新是自行注射市場的關鍵趨勢，領先的公司專注於開發新產品以增強其競爭地位。例如，2022 年 9 月，日本醫療設備製造商Terumo Corporation推出了 FineGlide，這是一款無菌筆式針頭，專為需要定期注射胰島素和其他自我治療的患者設計。 FineGlide 將患者的舒適度放在首位，採用三斜面超鋒利針頭和優質矽膠表面，確保注射輕柔。薄壁技術的加入提高了流速並減少了注射力，提高了患者的整體舒適度並促進了用藥依從性。這種對產品創新的關注表明了領先公司致力於滿足自行注射市場患者不斷變化的需求。

自行注射市場包括自動注射器、無針注射器、筆式注射器和穿戴式注射器的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球自行注射：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球自行注射市場：成長率分析
  • 全球自行注射市場表現：規模與成長，2019-2024
  • 全球自行注射市場預測：規模與成長，2024-2029 年，2034 年
  • 全球自行注射：總可尋址市場（TAM）

第6章 市場細分

  • 全球自行注射市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 裝置
  • 配方
  • 全球自行注射市場（依給藥途徑）：2019-2024 年、2024-2029 年、2034 年表現與預測
  • 皮膚
  • 循環系統或肌肉骨骼系統
  • 器官
  • 中樞神經系統
  • 全球自行注射市場（按劑量、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 單一劑量
  • 多劑量
  • 全球自行注射市場的應用、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 自體免疫疾病
  • 荷爾蒙失調
  • 腫瘤學
  • 罕見疾病
  • 疼痛管理
  • 呼吸治療
  • 其他
  • 全球自行注射市場（依通路）：2019-2024 年、2024-2029 年、2034 年業績及預測
  • 醫院藥房
  • 診所
  • 化學家
  • 網路藥局
  • 全球自行注射市場：設備細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 預填充式注射器
  • 自動注射器
  • 微針裝置
  • 穿戴式注射器
  • 全球自行注射市場：配方細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 生技藥品
  • 疫苗
  • 小分子
  • 組合產品

第7章 區域和國家分析

  • 全球自行注射市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球自行注射市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 自行注射市場：競爭格局
  • 自行注射市場：公司簡介
    • AbbVie Inc.
    • Antares Pharma Inc.
    • Baxter International Inc.
    • Bayer AG
    • Becton Dickinson and Company

第31章：其他領先和創新企業

  • Bristol-Myers Squibb Company
  • Credence MedSystems Inc.
  • Dali Medical Devices Ltd.
  • Eli Lilly and Company
  • Enable Injections Inc.
  • Gerresheimer AG
  • Insulet Corporation
  • Merck & Co. Inc.
  • Owen Mumford Limited
  • Pfizer Inc.
  • PharmaJet Inc.
  • Recipharm AB
  • Schott AG
  • SHL Group Limited
  • Terumo Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年自行注射市場：提供新機會的國家
  • 2029 年自行注射市場：細分市場帶來新機會
  • 2029年自行注射市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r22934u

Self-injection refers to the act of administering medications or drugs through a device by an individual to themselves without the assistance of a medical professional. This practice allows patients to independently manage their medication regimen.

The primary types of self-injections encompass devices and formulations. These devices enable patients to self-administer medications that require injection without relying on medical professionals. Self-injection devices are utilized for various routes of administration such as skin, circulatory or musculoskeletal systems, organs, and the central nervous system. Dosage types include single-dose and multi-dose, catering to applications in autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. These devices are distributed through various channels including hospitals, pharmacies, clinics, chemists, and online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The self injections market research report is one of a series of new reports from The Business Research Company that provides self injections market statistics, including self injections industry global market size, regional shares, competitors with a self injections market share, detailed self injections market segments, market trends and opportunities, and any further data you may need to thrive in the self injections industry. This self injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The self-injections market size has grown strongly in recent years. It will grow from $9.69 billion in 2024 to $10.22 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to rising chronic diseases, improved patient empowerment, regulatory support, preference for home healthcare, cost-effectiveness.

The self-injections market size is expected to see strong growth in the next few years. It will grow to $13.93 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to pandemic impact and remote treatment, expansion into emerging markets, patient-centric healthcare, advantages in drug delivery, personalized medicine trends. Major trends in the forecast period include smart technology integration, rise in biologics usage, miniaturization and wearable devices, enhanced safety features, adoption of autoinjectors.

The forecast of 8.1% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher costs for autoinjector springs and dose-counting mechanisms, predominantly supplied by Sweden and Denmark, impacting chronic disease management devices.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing number of diabetic patients is anticipated to drive the growth of the self-injections market in the future. Diabetes is a condition where the pancreas, an organ responsible for producing insulin, generates an insufficient amount of insulin, leading to the breakdown of blood sugar and resulting in severe health conditions such as heart disease, vision loss, and kidney disease. Self-injections allow diabetic patients to administer insulin and other medications themselves, helping to regulate blood sugar levels and prevent excess sugar without the need for assistance from a medical professional. For example, according to the IDF Diabetes Atlas, a Belgium-based global resource offering comprehensive data on diabetes prevalence, treatment, and care, the global number of diabetes cases is expected to rise from 643 million in 2030 to 783 million by 2045, an increase of 140 million cases. Currently, 537 million adults live with diabetes, with more than 75% residing in low- and middle-income countries. Therefore, the growing number of diabetic patients is significantly contributing to the expansion of the self-injections market.

The rise of telehealth and telemedicine is expected to drive the growth of the self-injections market in the future. Telehealth involves the use of telecommunications technology to deliver a wide range of healthcare services and information remotely, while telemedicine focuses specifically on remote clinical consultations and healthcare delivery. These digital health platforms enable virtual consultations, allowing healthcare providers to prescribe self-injectable medications from a distance. Patients also benefit from virtual training sessions that ensure they administer self-injections correctly. Additionally, telehealth facilitates real-time monitoring of patient adherence, ongoing disease management, and easy access to telepharmacy services for medication delivery. The convenience of telehealth, especially during pandemics, enhances patient engagement and improves overall access to specialized care, significantly contributing to the growth of the self-injections market. For example, according to Telehealth.HHS.gov, a U.S. government information provider, telehealth usage reached approximately 21,883,731 users in Q4 2023, marking an increase of 2,783,159 users, or 13%, compared to the previous quarter. Thus, the increase in telehealth and telemedicine is driving the expansion of the self-injections market.

Innovation in insulin injection solutions is a key trend in the self-injections market, with major companies focusing on developing new products to gain a competitive edge. For example, in September 2022, Terumo Corporation, a Japan-based medical device company, launched FineGlide, a sterile pen needle designed for patients requiring regular insulin injections or other self-medication. FineGlide prioritizes patient comfort by featuring a 3-bevel super sharp needle with a high-grade silicone surface, ensuring gentleness during injections. The inclusion of Thin Wall Technology improves flow rate and reduces injection force, enhancing the overall experience for patients and promoting drug compliance. This focus on product innovation demonstrates the commitment of major companies to meet the evolving needs of patients in the self-injections market.

Major players in the self-injections market are focusing on the development of smart injecting devices to gain a competitive advantage. In March 2022, Pfizer Inc., a prominent US-based pharmaceutical company, introduced ENBREL SmartClic in Australia. This innovative self-injecting device is designed for patients undergoing treatment with ENBREL, a tumor necrosis factor (TNF) inhibitor prescribed for conditions like Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), and Psoriatic Arthritis (PsA). ENBREL SmartClic features an automated, reusable design with user-friendly elements, including a one-button initiation, a larger grip compared to the Enbrel Auto-Injector, and injection speed control. The device is accompanied by a smartphone app, providing additional features such as reminders, injection history recording, site tracking, and streamlined reports. Patients can access these features on their smartphones and share the information with healthcare professionals, enhancing the overall self-injection experience for those dealing with chronic inflammatory diseases.

In June 2022, Dr. Reddy Labs, an India-based pharmaceutical manufacturer, made a significant acquisition by purchasing an injectable portfolio from Eton Pharma for $50 million. This strategic move by Dr. Reddy's aimed to accelerate and expand the availability of affordable medications for patients. The acquisition included new portfolios such as injections and recipes, allowing Dr. Reddy's to diversify its product offerings and strengthen its position in the pharmaceutical market. Eton Pharma, a US-based pharmaceutical manufacturer, contributed to Dr. Reddy's efforts to broaden its pharmaceutical portfolio, signaling a strategic expansion into injectable medications.

Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.

North America was the largest region in the self injections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the self-injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The self injections market consists of sales of auto-injectors, needle-free injectors, pen injectors and wearable injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Self-Injections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on self-injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for self-injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The self-injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Devices; Formulations
  • 2) By Route Of Administration: Skin; Circulatory Or Musculoskeletal; Organs; Central Nervous System
  • 3) By Dosage: Single Dose; Multi Dose
  • 4) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
  • 5) By Distribution Channel: Hospitals Pharmacies; Clinics; Chemist; Online Pharmacies
  • Subsegments:
  • 1) By Devices: Pre-Filled Syringes; Auto-Injectors; Microneedle Devices; Wearable Injectors
  • 2) By Formulations: Biologics; Vaccines; Small Molecules; Combination Products
  • Companies Mentioned: AbbVie Inc.; Antares Pharma Inc.; Baxter International Inc.; Bayer AG; Becton Dickinson and Company; Bristol-Myers Squibb Company; Credence MedSystems Inc.; Dali Medical Devices Ltd.; Eli Lilly and Company; Enable Injections Inc.; Gerresheimer AG; Insulet Corporation; Merck & Co. Inc.; Owen Mumford Limited; Pfizer Inc.; PharmaJet Inc.; Recipharm AB; Schott AG; SHL Group Limited; Terumo Corporation; West Pharmaceutical Services Inc.; Wilhelm Haselmeier GmbH & Co. KG; Ypsomed Holding AG; APTAR PHARMA INDIA PVT LTD; Bespak Europe Ltd.; Bioject Medical Technologies Inc.; Catalent Inc.; Crossject SA; Injex Pharma AG; Medeca Pharma AB; Medimop Medical Projects Ltd.; Mylan N.V.; Nemera Development S.A.; Noble Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Self-Injections Market Characteristics

3. Self-Injections Market Trends And Strategies

4. Self-Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Self-Injections Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Self-Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Self-Injections Market Growth Rate Analysis
  • 5.4. Global Self-Injections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Self-Injections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Self-Injections Total Addressable Market (TAM)

6. Self-Injections Market Segmentation

  • 6.1. Global Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Devices
  • Formulations
  • 6.2. Global Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Skin
  • Circulatory Or Musculoskeletal
  • Organs
  • Central Nervous System
  • 6.3. Global Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Dose
  • Multi Dose
  • 6.4. Global Self-Injections Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Pain Management
  • Respiratory Therapy
  • Other Applications
  • 6.5. Global Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals Pharmacies
  • Clinics
  • Chemist
  • Online Pharmacies
  • 6.6. Global Self-Injections Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pre-Filled Syringes
  • Auto-Injectors
  • Microneedle Devices
  • Wearable Injectors
  • 6.7. Global Self-Injections Market, Sub-Segmentation Of Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biologics
  • Vaccines
  • Small Molecules
  • Combination Products

7. Self-Injections Market Regional And Country Analysis

  • 7.1. Global Self-Injections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Self-Injections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Self-Injections Market

  • 8.1. Asia-Pacific Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Self-Injections Market

  • 9.1. China Self-Injections Market Overview
  • 9.2. China Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Self-Injections Market

  • 10.1. India Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Self-Injections Market

  • 11.1. Japan Self-Injections Market Overview
  • 11.2. Japan Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Self-Injections Market

  • 12.1. Australia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Self-Injections Market

  • 13.1. Indonesia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Self-Injections Market

  • 14.1. South Korea Self-Injections Market Overview
  • 14.2. South Korea Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Self-Injections Market

  • 15.1. Western Europe Self-Injections Market Overview
  • 15.2. Western Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Self-Injections Market

  • 16.1. UK Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Self-Injections Market

  • 17.1. Germany Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Self-Injections Market

  • 18.1. France Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Self-Injections Market

  • 19.1. Italy Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Self-Injections Market

  • 20.1. Spain Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Self-Injections Market

  • 21.1. Eastern Europe Self-Injections Market Overview
  • 21.2. Eastern Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Self-Injections Market

  • 22.1. Russia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Self-Injections Market

  • 23.1. North America Self-Injections Market Overview
  • 23.2. North America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Self-Injections Market

  • 24.1. USA Self-Injections Market Overview
  • 24.2. USA Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Self-Injections Market

  • 25.1. Canada Self-Injections Market Overview
  • 25.2. Canada Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Self-Injections Market

  • 26.1. South America Self-Injections Market Overview
  • 26.2. South America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Self-Injections Market

  • 27.1. Brazil Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Self-Injections Market

  • 28.1. Middle East Self-Injections Market Overview
  • 28.2. Middle East Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Self-Injections Market

  • 29.1. Africa Self-Injections Market Overview
  • 29.2. Africa Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Self-Injections Market Competitive Landscape And Company Profiles

  • 30.1. Self-Injections Market Competitive Landscape
  • 30.2. Self-Injections Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Antares Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Self-Injections Market Other Major And Innovative Companies

  • 31.1. Bristol-Myers Squibb Company
  • 31.2. Credence MedSystems Inc.
  • 31.3. Dali Medical Devices Ltd.
  • 31.4. Eli Lilly and Company
  • 31.5. Enable Injections Inc.
  • 31.6. Gerresheimer AG
  • 31.7. Insulet Corporation
  • 31.8. Merck & Co. Inc.
  • 31.9. Owen Mumford Limited
  • 31.10. Pfizer Inc.
  • 31.11. PharmaJet Inc.
  • 31.12. Recipharm AB
  • 31.13. Schott AG
  • 31.14. SHL Group Limited
  • 31.15. Terumo Corporation

32. Global Self-Injections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Self-Injections Market

34. Recent Developments In The Self-Injections Market

35. Self-Injections Market High Potential Countries, Segments and Strategies

  • 35.1 Self-Injections Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Self-Injections Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Self-Injections Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer